Mali
5 Vaccines Approved for Use in Mali
Non Replicating Viral Vector
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: reliefweb.int
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Approval Source: reuters.com
Inactivated
Sinovac
CoronaVac
Approved in 56 countries
42 trials in 10 countries
Approval Source: french.peopledaily.com.cn
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries
Approval Source: reliefweb.int
5 in Clinical Trials in Mali
Protein Subunit
Novavax
Nuvaxovid
Approved in 40 countries
22 trials in 14 countries
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries
Protein Subunit
Shanghai Zerun Biotechnology, Walvax Biotechnology
202-CoV
6 trials in 2 countries
Protein Subunit
Shanghai Zerun Biotechnology, Walvax Biotechnology
202a-CoV
2 trials in 1 country